2018-2023 Global Cystic Fibrosis (CF) Therapeutics Market Report (Status and Outlook)

October 2018 | 136 pages | ID: 27F414B8016EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Cystic Fibrosis (CF) Therapeutics market for 2018-2023.

Cystic Fibrosis is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys and intestine.
CF is inherited in an autosomal recessive manner. It is caused by the presence of mutations in both copies of the gene for the cystic fibrosis transmembrane conductance regulator protein.
Over the next five years, LPI(LP Information) projects that Cystic Fibrosis (CF) Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Cystic Fibrosis (CF) Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• CFTR Modulators
• Mucolytics
• Bronchodilators

Segmentation by application:

• Medical Application
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• AbbVie
• F. Hoffmann-La Roche
• Gilead
• Novartis
• Vertex Pharmaceuticals
• Advanced Inhalation Therapies
• Alaxia
• Teva Pharmaceutical Industries
• Merck
• Alcresta Therapeutics
• Allergan
• AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Cystic Fibrosis (CF) Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Cystic Fibrosis (CF) Therapeutics market by identifying its various subsegments.
• Focuses on the key global Cystic Fibrosis (CF) Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Cystic Fibrosis (CF) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Cystic Fibrosis (CF) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cystic Fibrosis (CF) Therapeutics Market Size 2013-2023
  2.1.2 Cystic Fibrosis (CF) Therapeutics Market Size CAGR by Region
2.2 Cystic Fibrosis (CF) Therapeutics Segment by Type
  2.2.1 CFTR Modulators
  2.2.2 Mucolytics
  2.2.3 Pancreatic Enzyme Supplements
  2.2.4 Bronchodilators
2.3 Cystic Fibrosis (CF) Therapeutics Market Size by Type
  2.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
  2.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 Cystic Fibrosis (CF) Therapeutics Segment by Application
  2.4.1 Medical Application
  2.4.2 Others
2.5 Cystic Fibrosis (CF) Therapeutics Market Size by Application
  2.5.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
  2.5.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CYSTIC FIBROSIS (CF) THERAPEUTICS BY PLAYERS

3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Players
  3.1.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Players (2016-2018)
  3.1.2 Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global Cystic Fibrosis (CF) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CYSTIC FIBROSIS (CF) THERAPEUTICS BY REGIONS

4.1 Cystic Fibrosis (CF) Therapeutics Market Size by Regions
4.2 Americas Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.3 APAC Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size Growth
4.5 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Countries
5.2 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Type
5.3 Americas Cystic Fibrosis (CF) Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Countries
6.2 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Type
6.3 APAC Cystic Fibrosis (CF) Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Cystic Fibrosis (CF) Therapeutics by Countries
7.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type
7.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cystic Fibrosis (CF) Therapeutics by Countries
8.2 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type
8.3 Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CYSTIC FIBROSIS (CF) THERAPEUTICS MARKET FORECAST

10.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast (2018-2023)
10.2 Global Cystic Fibrosis (CF) Therapeutics Forecast by Regions
  10.2.1 Global Cystic Fibrosis (CF) Therapeutics Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Cystic Fibrosis (CF) Therapeutics Forecast by Type
10.8 Global Cystic Fibrosis (CF) Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 Company Details
  11.1.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.1.3 AbbVie Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 AbbVie News
11.2 F. Hoffmann-La Roche
  11.2.1 Company Details
  11.2.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.2.3 F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 F. Hoffmann-La Roche News
11.3 Gilead
  11.3.1 Company Details
  11.3.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.3.3 Gilead Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Gilead News
11.4 Novartis
  11.4.1 Company Details
  11.4.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.4.3 Novartis Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Novartis News
11.5 Vertex Pharmaceuticals
  11.5.1 Company Details
  11.5.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.5.3 Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Vertex Pharmaceuticals News
11.6 Advanced Inhalation Therapies
  11.6.1 Company Details
  11.6.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.6.3 Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Advanced Inhalation Therapies News
11.7 Alaxia
  11.7.1 Company Details
  11.7.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.7.3 Alaxia Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Alaxia News
11.8 Teva Pharmaceutical Industries
  11.8.1 Company Details
  11.8.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.8.3 Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Teva Pharmaceutical Industries News
11.9 Merck
  11.9.1 Company Details
  11.9.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.9.3 Merck Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Merck News
11.10 Alcresta Therapeutics
  11.10.1 Company Details
  11.10.2 Cystic Fibrosis (CF) Therapeutics Product Offered
  11.10.3 Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Alcresta Therapeutics News
11.11 Allergan
11.12 AstraZeneca

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Cystic Fibrosis (CF) Therapeutics
Figure Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table Cystic Fibrosis (CF) Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of CFTR Modulators
Table Major Players of Mucolytics
Table Major Players of Pancreatic Enzyme Supplements
Table Major Players of Bronchodilators
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global CFTR Modulators Market Size Growth Rate
Figure Global Mucolytics Market Size Growth Rate
Figure Global Pancreatic Enzyme Supplements Market Size Growth Rate
Figure Global Bronchodilators Market Size Growth Rate
Figure Cystic Fibrosis (CF) Therapeutics Consumed in Medical Application
Figure Global Cystic Fibrosis (CF) Therapeutics Market: Medical Application (2013-2018) ($ Millions)
Figure Global Medical Application YoY Growth ($ Millions)
Figure Cystic Fibrosis (CF) Therapeutics Consumed in Others
Figure Global Cystic Fibrosis (CF) Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size in Medical Application Growth Rate
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size in Others Growth Rate
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Players in 2017
Table Global Cystic Fibrosis (CF) Therapeutics Key Players Head office and Products Offered
Table Cystic Fibrosis (CF) Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure United States Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure China Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure Germany Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size Market Share by Application in 2017
Figure Egypt Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Cystic Fibrosis (CF) Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global Cystic Fibrosis (CF) Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure China Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure India Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure France Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries Cystic Fibrosis (CF) Therapeutics Market Size 2018-2023 ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Cystic Fibrosis (CF) Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure AbbVie Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Gilead Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Gilead Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Novartis Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Vertex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Advanced Inhalation Therapies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Advanced Inhalation Therapies Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Alaxia Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alaxia Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Alaxia Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Teva Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Merck Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Alcresta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (2016-2018)
Figure Alcresta Therapeutics Cystic Fibrosis (CF) Therapeutics Market Share (2016-2018)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors